INTRODUCTION
The importance of oxygen radicals and other activated oxygen species in tissue injury and disease is now widely recognized [1] . Recently, Ames et al. [2] proposed that uric acid may act as an important physiological antioxidant defence against such oxidative injuries. The basis for this hypothesis was the observation that uric acid is oxidized to allantoin (and other products) in a process that scavenges hydroxyl radicals ('OH), lipid hydroperoxide radicals, singlet molecular oxygen (102), and oxo-haem oxidants, while inhibiting lipid peroxidation. Earlier studies had also reported the ability of urate to scavenge 102 [3] and oxo-haem oxidants [4] , as well as the protective effect of urate on linoleic acid stability [5] and erythrocyte membrane integrity [6] . During the course of human evolution several mutational events have resulted in the loss of uricase activity (urate-->allantoin) and the development of an active kidney re-absorption system for urate. These factors combine to produce blood urate concentrations in man that are some 10 times higher than those found in most other mammals [7] . The accompanying loss of ascorbate synthetase activity during human evolution led Ames et al. [2] to propose that uric acid may have replaced some (but not all) of the antioxidant functions of ascorbic acid. A somewhat similar proposal was also made by Proctor [8] .
The antioxidant properties of uric acid discussed above involve urate oxidation via classical scavenger mechanisms. During the course of further studies, however, we noted that urate can also inhibit oxidative reactions without itself being oxidized. Specifically, we reported that uric acid appears to be necessary to prevent the oxidation of ascorbic acid in human blood, although no urate oxidation results from this protection [9] . The mechanism by which urate preserved ascorbate was not clear, but several alternatives were discussed. A key observation in the previous paper was the fact that metal-ion-chelating agents such as EDTA and DTPA almost completely inhibited the oxidation of ascorbate in human blood [9] . In the present paper we provide evidence that urate inhibits ascorbate oxidation, and ascorbate-dependent lipid peroxidation, by forming stable complexes with transition-metal ions such as iron ions. Ascorbate oxidation is largely metal-ion-dependent at neutral pH, and we propose that urate-Fe3+ complexes are ineffective catalysts of ascorbate oxidation. Our findings add a new dimension to the biological significance of uric acid as a primary 'antioxidant', and [10] . Subsequently, 0.5 vol. of 50% (w/v) trichloroacetic acid and an equal volume of 0.75% thiobarbituric acid in 0.1 M-HCI were added. The samples were boiled for 20 min, and thiobarbituric acid-reacting substances were determined spectrophotometrically at 532 nm. Uric acid had no effect on the thiobarbituric acid test itself under these conditions (or any others so far tested).
Microsomal fraction was isolated from the livers of male Sprague-Dawley rats (200-250 g body wt.) as previously described [12] . Protein was determined by the biuret procedure [13] . After incubation with ascorbate with or without Fe3+ in the presence and in the absence of urate, 0.5 vol. of 40% trichloroacetic acid was added and the protein was removed by centrifugation at 7000 g for 10 min at 4 'C. The supernatant fractions were then used to determine thiobarbituric acid-reactive substances as described above.
Measurements of urate-iron ion interaction
The iron-ion-binding properties of urate were determined by fluorescence-quenching experiments [14, 15] The electrical reduction potential for Fe3+ was measured by using a polarographic half-cell and a stationary platinum working electrode, referenced to a standard calomel electrode. Polarographic methods and precautions were followed as described by Adams [16] . Current-voltage measurements were made with a Princeton Applied Research model 1 74A polarographic analyser. Reduction potentials were determined in 10 mM-KCI, to which FeCl3 solutions in water were added to give final concentrations ranging from 50 to 200 /SM. All measurements were preceded by a 5 min gassing of the test solutions with N2, and all reagents were originally saturated with N2. A 10 mV/s scan rate was used over a 1.5 V range starting at 0.9 V. To examine the effect of uric acid on the Fe3+ reduction potential a KCI test solution was prepared to contain 500 jtM-urate, and FeCl3 was then added as described above. Five successive scans were made for each preparation studied, and the average reduction potentials were calculated from the polarograms.
RESULTS

Iron-ion-and pH-dependence of ascorbate oxidation
The oxidation of ascorbate was highly dependent on both Fe3+ concentration and pH (Fig. 1) . In the presence of 10 jtM-FeCl3, ascorbate oxidation was increased 4-5-fold by raising the pH from 6.5 to 10.0 (Fig. la) . At pH 7.5 ascorbate oxidation was stimulated by FeCl3 concentrations up to 10 uM, but higher FeCl3 concentrations (up to 100 /M) produced no further stimulation (Fig. lb) . At pH 7.5, with 10 gM-FeCl3, the addition of 100 uM-EDTA or -DTPA (1:1 ratios with ascorbate) decreased ascorbate oxidation rates to 8% and 2 % (respectively) of the values reported in Fig. 1(b) In the presence of 10 /LM-Fe3+ (pH 7.5), the oxidation mM-potassium of 100 /LM-ascorbate was strongly inhibited by urate (Fig.  2) . The degree to which urate inhibited ascorbate oxidation was a function of the urate/ascorbate ratio. At a urate/ascorbate ratio of 10: 1, the inhibition of ascorbof the iron-ion ate oxidation was approx. 97%. The concentrationletected. These dependent inhibition by urate was found to be biphasic, ndings [17] that with the greatest increase in inhibition occurring at X rates increase urate/ascorbate ratios in the range 0-2:1 (82% [19] . In this procedure the rate of ascorbate oxidation (in the presence and the absence of urate) was measured in the absence and in the presence of the radical-propagating species azobis-(2-amidinopropane hydrochloride). The oxidation of ascorbate occurs by two one-electron transfers, with the ascorbyl radical as the intermediary state. The rate-limiting step in the overall process is the first one-electron oxidation to the ascorbyl radical [21] . As shown in Fig. 3 , production of ascorbyl radicals is greatly diminished by the addition of urate. The inhibition curve for Fig. 3 shows excellent agreement with that for Fig. 2 , indicating that urate probably exerts its major effect by inhibiting the oxidation of dihydroascorbate to the ascorbyl radical (monohydroascorbate). This reasoning is further supported by the observation that rapid mixing of urate with an ascorbyl radical solution had little effect on the further oxidation of the ascorbyl radical to dehydroascorbate (results not shown). As might be expected, strong inhibition of (Fe3+-dependent) ascorbyl radical production was provided by the iron-ion chelators EDTA (95 % ) and DTPA (98 0 ) at 1: 1 concentration ratios with ascorbate.
Since urate inhibits the iron-ion-dependent oxidation of dihydroascorbate to the ascorbyl radical without urate oxidation, Fe3+ reduction or ascorbate binding, we wondered if urate might form a stable complex with Fe3+. This possibility is explored in the next section. Formation of iron ion complexes by urate Albert [22] has reported that urate and other purines have the ability to bind iron ions. Unfortunately, experimental difficulties have prevented the accurate determination of stability constants of urate-iron ion complexes. In our own studies we have found that potentiometric and spectrophotometric methods are not suitable for the study of urate-iron ion complexes owing to problems with solubility and pH-dependent oxidation/ reduction reactions. We have therefore employed fluorescence-quenching techniques [14, 15] If urate could only form 1: 1 complexes with iron ions, the Ka values determined above would also represent stability constants (Ks). Further experiments, however, revealed that the binding ofthe first urate molecule to iron ion facilitates the binding of a second urate molecule. In these experiments we measured the ability of relatively low (7-400 ,lM) concentrations of iron salts to quench the fluorescence of a more-concentrated urate solution (500,lM). Plots of IO -I versus FeCl3 concentration revealed increasing fluorescence quenching up to a urate/Fe3+ ratio ofapprox. 2: 1 (i.e. 500 ,tM-urate/250 /tMFeCl3), at which point maximal quenching was attained. Double-reciprocal plots revealed a clear sigmoidal relationship, indicative of 'co-operativity'. Doublelogarithmic plots of these data were used to determine the Hill coefficient for the formation of urate-Fe3+ 2:1 complex (Fig. 4b) . A Hill coefficient of 1.86 was determined from the slope of Fig. 4(b In the presence of 10 /tM-FeCl3 and 100 #M-ascorbate, the peroxidation of unsaturated fatty acids in unilamellar liposomes was readily observed (Fig. 5 ). The addition of urate decreased both the rate of ascorbate oxidation and the extent of lipid peroxidation, in a concentrationdependent manner. At an urate/ascorbate ratio of 10:1 (close to the situation in human blood) lipid peroxidation was inhibited by approx. 76% (Fig. 5) . In comparison, ascorbate oxidation was inhibited by approx. 97% at a urate/ascorbate ratio of 10:1 (see Fig. 2 ). The inhibition curve for urate addition plotted versus malondialdehyde concentration (Fig. 5) was somewhat more shallow than the curve for urate addition plotted versus ascorbate oxidation (Fig. 2) , with less inhibition occurring at low urate/ascorbate ratios. Nevertheless, the inhibitory effect of urate on liposomal lipid peroxidation was striking. The overall reaction scheme for the oxidation of ascorbic acid by Fe3+ may be summarized by eqns. (1)- (4) below:
AH2+Fe3+-AH-+Fe2+
Fe2+ O2 Fe3+ + O°-AHW+O2-A+O;
Overall:
AH2+202-*A+202 (4) Eqns. (1) and (3) (1), which is the rate-limiting step [21] . Several other possible explanations for the preservation of dihydroascorbate .by urate have been ruled out. These include: (1) urate oxidation in a classical antioxidant scavenger reaction; (2) re-reduction of oxidized ascorbate by urate; (3) Fe3+ reduction to Fe2+ by urate (at pH 7.4); (4) inhibition of ascorbate radical chain reactions (ascorbate shows no evidence of chain oxidation); (5) inhibition of Fe2+ re-oxidation to Fe3+; (6) inhibition of ascorbyl radical oxidation to dehydroascorbate; (7) formation of a stable urate-ascorbate hydrogen-bonded complex.
When we first proposed that urate could inhibit ascorbate oxidation and lipid peroxidation by forming co-ordination complexes with iron ions, we had only indirect evidence for urate-iron ion binding [25] . Shortly thereafter, Lam et al. [26] proposed that urate could inhibit copper-ion-dependent ascorbate oxidation by formation ofstable urate-Cu+ complexes. Unfortunately, Lam et al. were also unable to provide any direct evidence for the formation or stability of urate-copper ion complexes [26] . Smith & Lawing [27] had already shown that both urate and ribosylurate protected against copper-ion-induced peroxidation of arachidonate, linolenate and erythrocyte membrane lipids. By using e.s.r. techniques, we have recently found that urate also binds copper and manganese ions (K. J. A. Davies, unpublished work). It is therefore possible that the formation of urate-metal ion complexes may be a general mechanism whereby urate can inhibit the oxidation of ascorbate by transition-metal ions.
Recently we reported that uric acid appears to be responsible for the preservation ofascorbic acid in human blood [9] . Ascorbate oxidation in human serum showed evidence of dependence on endogenous transition-metal ions, and was inhibited by as much as 7500 in the presence of physiological concentrations of urate; no urate oxidation was observed in these experiments [9] . The present results provide a clear rationale for the preservation of ascorbic acid in human blood, via scavenging of transition-metal ions by uric acid. Such thoughts take on greater significance when one considers that the evolutionary pressures which led to the loss of ascorbate synthetase activity in humans have also been accompanied by the loss of uricase activity and the development of efficient renal systems for the reabsorbtion of urate [2] .
The effectiveness of ascorbate as a biological antioxidant may be limited by its propensity to oxidize, generating oxygen radicals and mutagens [24] , and initiating lipid peroxidation [2] . Such properties represent Vol. 235 the paradox of several common antioxidants, and may be viewed as a consequence of their somewhat delicate biological 'redox poise'. Ames et al. reported that uric acid is a highly effective scavenger in several lipid peroxidation systems, including y-irradiation ('OH), photo-oxidation (102), haematin or haemoglobin + H202 (oxo-haem oxidants) and lipid hydroperoxides. Urate was also found to protect against the oxidative haemolysis of erythrocyte membranes by lipid hydroperoxides [2] or xanthine oxidase + acetaldehyde [2, 6] . A feature common to all systems in which urate inhibits peroxidation by quenching active species is that urate is oxidized to allantoin, and other products, in the process. In the present paper we have demonstrated an additional anti(per)oxidant activity of uric acid that is dependent upon its metal-ion-binding properties. As shown in eqn. (4) above, the oxidation of ascorbate produces two molecules of0-. The 0°-so produced may then proceed, via iron-ion-catalysed Haber-Weiss reactions [28] , Fenton reactions [29] or other (less-well-defined) chemistry [30] , to initiate lipid peroxidation in liposomes and microsomal fraction ( Fig. 5 and Table 2 ). The formation ofurate-iron ion complexes prevents the initial generation of°2-(since ascorbate is prevented from oxidizing) and so inhibits lipid peroxidation without causing urate oxidation. Although urate would also be expected to decrease lipid peroxidation in such systems by scavenging 'OH or other oxidants [2] , our results indicate that the greater effect may be inhibition of the initial radicalproducing step, iron-ion-catalysed ascorbate oxidation.
The effectiveness of urate as an inhibitor of ascorbate oxidation and lipid peroxidation in the present investigation, and in our previous work [9] , was found to be a function of the urate/ascorbate concentration ratio. Concentrations of urate greatly in excess of available iron ions were used, which might imply an interaction between urate and ascorbate rather than between urate and iron ions. N.m.r. studies, however, revealed no such interaction between urate and ascorbate, and our results may be better explained on the basis of urate competition with ascorbate for available Fe3+. On the basis of the approximate stability constants for Fe3+ complexes with urate (approx. 1011) and ascorbate (approx. 102) one would predict that urate should be an effective inhibitor of ascorbate oxidation and lipid peroxidation at a 1:1 concentration ratio with ascorbate (although exact inhibition is difficult to predict, because of the nonlimiting oxidation rate of the ascorbyl radical). In agreement with this prediction, a 72% inhibition of ascorbate oxidation was observed at a urate/ascorbate ratio of 1.0:1 (Fig. 2) . Predictions of peroxidation inhibition would be extremely difficult, owing to the tremendous complications contributed by radical-propagation reactions.
The importance of transition-metal ions, such as iron and copper ions, in free-radical reactions is now widely recognized [28] [29] [30] . Debate continues over the physiological forms of catalytic transition-metal ions, but this is likely to be a protracted discussion. Intracellular and extracellular fluids contain many metalloproteins and metal-ion-binding/transport proteins and a host of small molecules that can form stable co-ordination complexes with metal ions. In the presence of multiple complexforming agents, the distribution of transition-metal ions will be a function both of individual stability constants and the relative concentration of each agent. It is important to note that a dynamic equilibrium must be reached in which each complex-forming agent will bind some of the available metal ion(s). Our estimate of 1.1 x 1011 for the overall stability constant of formation of the urate-Fe3+ complex, combined with the high concentration of urate normally found in human plasma, suggests that urate may be one of the major low-Mr iron-ion-binding agents in human blood. This hypothesis is given greater significance by our previous report that urate protects ascorbate against iron-ion-catalysed oxidation in human blood, without itself undergoing oxidation [9] . We propose that the newly demonstrated iron-ion-binding properties of uric acid, combined with its previously described scavenger functions [2] , provide further evidence for the theory that urate plays a major role in the antioxidant defences of human beings.
